Indiana Hemophilia and Thrombosis Center — Indianapolis, Indiana

Indiana Hemophilia and Thrombosis Center is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana Hemophilia and Thrombosis Center has participated in 28 clinical trials with 5 currently active.

Therapeutic areas: Acquired Hemophilia A, Prevent Bleeding in Major Surgery, Hypoplasminogenemia.

Sponsors: Baxalta now part of Shire, Octapharma, Prometic Biotherapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana Hemophilia and Thrombosis Center?

Indiana Hemophilia and Thrombosis Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana Hemophilia and Thrombosis Center conducted?

Indiana Hemophilia and Thrombosis Center has 28 clinical trials on record, with 5 currently active. Their work covers Acquired Hemophilia A, Prevent Bleeding in Major Surgery, Hypoplasminogenemia.

Is Indiana Hemophilia and Thrombosis Center accredited by Crixeo Health?

Indiana Hemophilia and Thrombosis Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana Hemophilia and Thrombosis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.